Decreased concentration of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with X-linked hypophosphatemic rickets: effect of phosphate supplementation.
暂无分享,去创建一个
H. Tanaka | Y. Seino | S. Nakajima | K. Yamaoka | T. Yamamoto | S. Okada
[1] H. DeLuca,et al. 1,25-Dihydroxyvitamin D3 up-regulates the 1,25-dihydroxyvitamin D3 receptor in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[2] H. Tanaka,et al. Effect of single oral phosphate loading on vitamin D metabolites in normal subjects and in X-linked hypophosphatemic rickets. , 1989, Bone and mineral.
[3] M. Haussler,et al. Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells. , 1988, Endocrinology.
[4] H. Tanaka,et al. Effects of the administration of phosphate on nuclear 1,25-dihydroxyvitamin D3 uptake by duodenal mucosal cells of Hyp mice. , 1988, Endocrinology.
[5] R. Morris,et al. Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D. , 1987, The Journal of clinical investigation.
[6] Y. Seino,et al. Decreased nuclear uptake of 1,25-dihydroxyvitamin D3 by duodenal mucosal cells in the X-linked hypophosphatemic mouse. , 1985, Endocrinology.
[7] Z. Hochberg,et al. Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D. , 1985, The Journal of clinical investigation.
[8] J. Adams,et al. Specific internalization and action of 1,25-dihydroxyvitamin D3 in cultured dermal fibroblasts from patients with X-linked hypophosphatemia. , 1984, The Journal of clinical endocrinology and metabolism.
[9] S. Krane,et al. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. , 1983, The Journal of clinical endocrinology and metabolism.
[10] S. Manolagas,et al. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. , 1983, Science.
[11] M. Drezner,et al. Abnormal regulation of renal 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the X-linked hypophosphatemic mouse. , 1983, The Journal of clinical investigation.
[12] L. Avioli,et al. lα, 25-DIHYDROXYVITAMIN D3 RECEPTOR IN THE X-LINKED HYPOPHOSPHATEMIC MOUSE. , 1982 .
[13] F. Glorieux,et al. X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization. , 1981, The Journal of clinical endocrinology and metabolism.
[14] M. Haussler,et al. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. , 1980, The Journal of clinical investigation.
[15] F. Glorieux,et al. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. , 1980, The New England journal of medicine.
[16] Y. Seino,et al. Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood. , 1980, Archives of disease in childhood.
[17] H. DeLuca,et al. Hypophosphatemic vitamin D-resistant rickets: metabolic balance studies in a child receiving 1,25 dihydroxyvitamin D3, phosphate, and ascorbic acid. , 1978, Pediatrics.
[18] F. Glorieux,et al. Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[19] A. Norman,et al. Actions of 1,25-dihydroxycholecalciferol in patients with hypophosphatemic, vitamin-D-resistant rickets. , 1973, The New England journal of medicine.
[20] F. Glorieux,et al. Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia. , 1972, The New England journal of medicine.
[21] F. Glorieux,et al. Loss of a Parathyroid Hormone-Sensitive Component of Phosphate Transport in X-Linked Hypophosphatemia , 1972, Science.
[22] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[23] F. Albright,et al. Rickets resistant to vitamin D therapy. , 1937 .
[24] S. Iacobelli,et al. Glucocorticoid receptors predict response to combination chemotherapy in patients with acute lymphoblastic leukemia. , 1987, Oncology.
[25] M. Haussler,et al. Abnormal relationship between serum phosphate concentration and renal 25-hydroxycholecalciferol-1-alpha-hydroxylase activity in X-linked hypophosphatemic mice. , 1986, Mineral and electrolyte metabolism.
[26] Y. Seino,et al. PLASMA CLEARANCE FOR HIGH DOSES OF EXOGENOUS 1,25-DIHYDROXY[23,24(n)- 3 H]CHOLECALCIFEROL IN X-LINKED HYPOPHOSPHATEMIC MICE , 1982 .
[27] Y. Seino,et al. Vitamin D metabolism in hypophosphatemic vitamin D-resistant rickets. , 1980, Contributions to nephrology.
[28] Y. Seino,et al. Competitive protein binding assay for plasma 25-hydroxycholecalciferol. , 1980, Methods in enzymology.